- ►mit.edu [PDF] P Carmeliet… - NATURE-LONDON-, 2005 - nature.com Cancer (activation of oncogenes; loss of tumor suppressors) and metastasis;
infectious diseases (pathogens express (lymph)-angiogenic genes 1 , induce
(lymph)-angiogenic programs 2 or transform ECs 3, 4 ; antimicrobial ... Cited by 711 - Related articles - BL Direct - All 15 versions
- ►aacrjournals.org P Nyberg, L Xie, R Kalluri - Cancer research, 2005 - AACR Angiogenesis, the formation of new blood vessels, is required for many
pathologic processes, including invasive tumor growth as well as physiologic
organ/tissue maintenance. Angiogenesis during development and adulthood is ... Cited by 203 - Related articles - All 3 versions
- ►physiology.org [PDF] S Ohga, K Shikata, K Yozai, S Okada, D … - American Journal of Physiology- Renal Physiology, 2006 - Am Physiological Soc Page 1. Ohga et al., Page 1 Original Article Thiazolidinedione ameliorates
renal injury in experimental diabetic rats through anti ... Cited by 39 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org K Ichinose, Y Maeshima, Y Yamamoto, H … - Diabetes, 2005 - Am Diabetes Assoc Diabetic nephropathy is one of the major microvascular complications in diabetes
and is the leading cause of end-stage renal disease worldwide. Among various
factors, angiogenesis-associated factors such as vascular endothelial ... Cited by 40 - Related articles - BL Direct - All 6 versions
- ►physiology.org [PDF] P Roestenberg, FA van Nieuwenhoven, JA … - American Journal of Physiology- Renal Physiology, 2006 - Am Physiological Soc 59 articles, 37 of which you can access free at: This article cites
http://ajprenal.physiology.org/cgi/content/full/290/6/F1344#BIBL ... 6 other
HighWire hosted articles, the first 5 are: This article has been cited by Cited by 38 - Related articles - BL Direct - All 6 versions
- ►asnjournals.org MEJ Reinders, TJ Rabelink, DM Briscoe - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol This review discusses the concept that the turnover and replacement of
endothelial cells is a major mechanism in the maintenance of vascular integrity
within the kidney. CD133 + CD34 + KDR + endothelial cell progenitor cells ... Cited by 37 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org H Sugimoto, G Grahovac, M Zeisberg, R … - Diabetes, 2007 - Am Diabetes Assoc Diabetic nephropathy is currently the most common cause of end-stage renal
disease (ESRD) in the western world. A mouse model for diabetic nephropathy that
encompasses the salient features of this disease in the kidney is not ... Cited by 31 - Related articles - BL Direct - All 5 versions
- ►oxfordjournals.org BF Schrijvers, A Flyvbjerg, RG Tilton, NH … - Nephrology Dialysis Transplantation, 2006 - ERA-EDTA Background. Antagonism of vascular endothelial growth factor (VEGF) has improved
the outcome in experimental nephropathies of various origins, including diabetic
nephropathy in a type 1 diabetic rat model and a type 2 diabetic mouse ... Cited by 27 - Related articles - BL Direct - All 5 versions
HJ Baelde, M Eikmans, DWP Lappin, PP Doran, … - Kidney international, 2007 - nature.com Micro-vascular and renal complications in diabetic patients are a considerable
clinical challenge. In a previous study, we found a significant decrease in
vascular endothelial growth factor A (VEGF-A) mRNA levels in glomeruli from ... Cited by 25 - Related articles - BL Direct - All 5 versions
SM Marshall - Current pharmaceutical design, 2007 - ingentaconnect.com Abstract: Over the last five years, much work has underlined the important role
of the podocyte in the development of diabetic neph- ropathy. The metabolic and
haemodynamic abnormalities of the diabetic milieu act in concert, perhaps ... Cited by 25 - Related articles - BL Direct - All 4 versions
